Meet us at Bio 2017, San Diego (Booth Number 5243b, India Pavilion)

Developing Innovative Biologics

We combine two technology platforms to create new glyco-engineered monoclonal antibodies which identify unique target epitopes

WHY ZUMUTOR?

People

A combined experience exceeding 100 years.
Expertise in antibody engineering and process development.

Infrastructure

Well-equipped 14,785 sqft Lab for complete process development.
ISO 9001:2008 Certified

Intellectual Property

A number of provisional patents focusing on novel biomolecules and biosimilars filed.